Literature DB >> 26497613

Should we treat heart failure with phosphatase inhibitors? Better to start at the end.

Brandon J Biesiadecki1, Mark T Ziolo2.   

Abstract

Entities:  

Keywords:  Myofilament phosphorlyation; PP1; Troponin I

Mesh：

Substances：

Year:  2015        PMID： 26497613      PMCID： PMC4689650          DOI： 10.1016/j.yjmcc.2015.10.020

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN： 0022-2828            Impact factor:   5.000


× No keyword cloud information.
  30 in total

1.  When is cAMP not cAMP? Effects of compartmentalization.

Authors:  D M Bers; M T Ziolo
Journal:  Circ Res       Date:  2001-08-31       Impact factor: 17.367

2.  Type 1 phosphatase, a negative regulator of cardiac function.

Authors:  Andrew N Carr; Albrecht G Schmidt; Yoichi Suzuki; Federica del Monte; Yoji Sato; Carita Lanner; Kristine Breeden; Shao-Ling Jing; Patrick B Allen; Paul Greengard; Atsuko Yatani; Brian D Hoit; Ingrid L Grupp; Roger J Hajjar; Anna A DePaoli-Roach; Evangelia G Kranias
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

3.  Cardiac SR-coupled PP1 activity and expression are increased and inhibitor 1 protein expression is decreased in failing hearts.

Authors:  Ramesh C Gupta; Sudhish Mishra; Sharad Rastogi; Makoto Imai; Omar Habib; Hani N Sabbah
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-12       Impact factor: 4.733

4.  Enhancement of cardiac function and suppression of heart failure progression by inhibition of protein phosphatase 1.

Authors:  Anand Pathak; Federica del Monte; Wen Zhao; Jo-El Schultz; John N Lorenz; Ilona Bodi; Doug Weiser; Harvey Hahn; Andrew N Carr; Faisal Syed; Nirmala Mavila; Leena Jha; Jiang Qian; Yehia Marreez; Guoli Chen; Dennis W McGraw; E Kevin Heist; J Luis Guerrero; Anna A DePaoli-Roach; Roger J Hajjar; Evangelia G Kranias
Journal:  Circ Res       Date:  2005-03-03       Impact factor: 17.367

Review 5.  Abnormalities of calcium cycling in the hypertrophied and failing heart.

Authors:  S R Houser; V Piacentino; J Weisser
Journal:  J Mol Cell Cardiol       Date:  2000-09       Impact factor: 5.000

6.  Specific enhancement of sarcomeric response to Ca2+ protects murine myocardium against ischemia-reperfusion dysfunction.

Authors:  Grace M Arteaga; Chad M Warren; Sanja Milutinovic; Anne F Martin; R John Solaro
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-07-15       Impact factor: 4.733

7.  Identification of the major protein phosphatases in mammalian cardiac muscle which dephosphorylate phospholamban.

Authors:  L K MacDougall; L R Jones; P Cohen
Journal:  Eur J Biochem       Date:  1991-03-28

Review 8.  Regulatory light chains of striated muscle myosin. Structure, function and malfunction.

Authors:  Danuta Szczesna
Journal:  Curr Drug Targets Cardiovasc Haematol Disord       Date:  2003-06

Review 9.  Functional diversity of protein phosphatase-1, a cellular economizer and reset button.

Authors:  Hugo Ceulemans; Mathieu Bollen
Journal:  Physiol Rev       Date:  2004-01       Impact factor: 37.312

10.  Cardiac-specific deletion of protein phosphatase 1β promotes increased myofilament protein phosphorylation and contractile alterations.

Authors:  Ruijie Liu; Robert N Correll; Jennifer Davis; Ronald J Vagnozzi; Allen J York; Michelle A Sargent; Angus C Nairn; Jeffery D Molkentin
Journal:  J Mol Cell Cardiol       Date:  2015-08-31       Impact factor: 5.000
View more
  1 in total

1.  Platelet proteome changes in dogs with congestive heart failure.

Authors:  Pinar Levent; Meriç Kocaturk; Emel Akgun; Ahmet Saril; Ozge Cevik; Ahmet Tarik Baykal; Ryou Tanaka; Jose Joaquin Ceron; Zeki Yilmaz
Journal:  BMC Vet Res       Date:  2020-11-30       Impact factor: 2.741
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.